SPAC5H10.01 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Overview

Abs-9 (SPAC5H10.01) is a fully human IgG1 antibody derived from memory B cells of volunteers immunized with a recombinant five-component S. aureus vaccine (rFSAV). It was selected from 676 antigen-binding clonotypes for its high affinity and prophylactic efficacy against drug-resistant S. aureus strains .

Mechanism of Action

Abs-9 binds to the α-helix region of SpA5, disrupting S. aureus immune evasion mechanisms. Structural modeling (AlphaFold2 and molecular docking) revealed the antibody-antigen complex involves hydrophobic and electrostatic interactions, with key residues E848, E849, and R851 mediating binding .

In Vivo Protection:

  • Mouse Sepsis Model:

    • Survival Rates: 80% (MRSA252), 85.7% (USA300), 60% (Newman) with Abs-9 vs. 0–20% in controls.

    • Statistical Significance: p<0.001p < 0.001 for all strains .

Epitope Identification

The epitope (N847-S857) was validated via:

  1. ELISA: KLH-conjugated peptide (N847-S857) showed strong binding to Abs-9.

  2. Competitive Binding: Synthetic peptide inhibited Abs-9 binding to SpA5 by 70–80% .

Research Implications

  • Therapeutic Potential: Abs-9’s broad-spectrum activity against MRSA highlights its promise as a monoclonal antibody therapy for antibiotic-resistant infections.

  • Vaccine Design: The epitope data informs engineering of SpA5-based vaccines to enhance immune recognition .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC5H10.01 antibody; Putative hydro-lyase C5H10.01 antibody; EC 4.2.1.- antibody
Target Names
SPAC5H10.01
Uniprot No.

Q&A

What is SPAC5H10.01 and why is it studied in research?

SPAC5H10.01 is a protein found in Schizosaccharomyces pombe (strain 972/ATCC 24843), commonly known as fission yeast. It is identified by UniProt accession number Q09674. This protein is studied as part of understanding fundamental cellular processes in S. pombe, which serves as an important model organism for eukaryotic cell biology. The protein's function may relate to cellular processes that are conserved across eukaryotes, making it valuable for comparative genomics and evolutionary studies. Antibodies against this protein allow researchers to track its expression, localization, and interactions within the cell .

What applications is SPAC5H10.01 Antibody most commonly used for?

The SPAC5H10.01 Antibody is primarily used in fundamental research applications including:

  • Western blotting for protein expression analysis

  • Immunohistochemistry (IHC) for localization studies

  • Immunoprecipitation (IP) for protein-protein interaction studies

  • Flow cytometry for quantitative analysis of protein expression in cell populations

  • Immunofluorescence microscopy for subcellular localization

Similar antibodies in research settings typically require optimization for each specific application, as seen with other research antibodies like HO-1 monoclonal antibody, which is recommended for flow cytometry, ICC, IHC, and Western blotting applications .

What are the recommended storage conditions for SPAC5H10.01 Antibody?

While specific storage information for SPAC5H10.01 Antibody isn't explicitly stated in the available search results, best practices based on similar research antibodies suggest:

  • Long-term storage: -20°C to -70°C

  • Short-term storage: 2-8°C under sterile conditions after reconstitution

  • Avoid repeated freeze-thaw cycles by aliquoting the antibody upon receipt

For comparison, similar antibodies like Human PU.1/Spi-1 Antibody recommend storage at -20 to -70°C for 12 months from receipt date, 2-8°C for 1 month under sterile conditions after reconstitution, or -20 to -70°C for 6 months under sterile conditions after reconstitution .

How should I optimize SPAC5H10.01 Antibody dilutions for different applications?

Optimization of antibody dilutions should follow a systematic approach:

  • Start with the manufacturer's recommended dilution range

  • Perform a dilution series experiment (typically 1:500, 1:1000, 1:2000, 1:5000)

  • Include appropriate positive and negative controls

  • Assess signal-to-noise ratio for each dilution

For Western blotting applications, similar antibodies are typically used at dilutions around 1:1000 with ECL detection systems. For example, HO-1 monoclonal antibody is recommended at 1:1,000 dilution for Western blot with ECL detection . For flow cytometry, a starting concentration of 10μg/ml may be appropriate, based on similar antibody recommendations. Remember that optimal conditions must be determined individually for each application and sample type .

What controls should I include when using SPAC5H10.01 Antibody?

A robust experimental design with appropriate controls is essential for antibody-based experiments:

Control TypePurposeImplementation
Positive ControlConfirms antibody worksSample known to express SPAC5H10.01
Negative ControlAssesses non-specific bindingSample known to not express SPAC5H10.01
Isotype ControlEvaluates backgroundSame species/isotype as primary antibody but non-targeting
Secondary-only ControlChecks secondary antibody specificityOmit primary antibody
Blocking Peptide ControlConfirms epitope specificityPre-incubate antibody with immunizing peptide

Similar approaches are used with other research antibodies, as seen in the detection of PU.1/Spi-1 in THP-1 cells by flow cytometry, where researchers used an isotype control antibody (Catalog # MAB004) alongside the target antibody .

What is the recommended protocol for immunoprecipitation using SPAC5H10.01 Antibody?

While specific protocols for SPAC5H10.01 Antibody are not available in the search results, a general immunoprecipitation protocol for yeast proteins would include:

  • Prepare yeast cell lysate under non-denaturing conditions

    • Lyse cells in buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 0.5% NP-40, and protease inhibitors

    • Homogenize using glass beads and vortexing in cycles of 30 seconds on/30 seconds off

    • Centrifuge at 14,000×g for 10 minutes at 4°C to remove debris

  • Pre-clear lysate with protein A/G beads for 1 hour at 4°C

  • Incubate pre-cleared lysate with SPAC5H10.01 Antibody (2-5μg per 500μg total protein) overnight at 4°C with gentle rotation

  • Add protein A/G beads and incubate for 2-4 hours at 4°C

  • Wash beads 4-5 times with IP buffer

  • Elute bound proteins by boiling in SDS sample buffer

  • Analyze by SDS-PAGE followed by Western blotting

This approach is similar to methods used for other antibody-antigen interactions in research settings, such as the approach used to confirm Abs-9 antibody specificity for SpA5 antigen .

How do I interpret weak or non-specific banding patterns when using SPAC5H10.01 Antibody in Western blots?

Weak or non-specific banding can result from several factors:

  • Antibody concentration: Too low concentration can result in weak signal; increase antibody concentration incrementally.

  • Protein expression level: SPAC5H10.01 may be expressed at low levels; increase total protein loaded or use enrichment techniques.

  • Detection system sensitivity: Switch to more sensitive detection systems like enhanced chemiluminescence (ECL).

  • Cross-reactivity: Non-specific bands may indicate cross-reactivity with similar epitopes; try more stringent washing or different blocking agents.

  • Protein degradation: Additional bands may represent degradation products; add more protease inhibitors during sample preparation.

For comparison, similar approaches are used when analyzing Western blot results for other antibodies, as demonstrated with Human PU.1/Spi-1 Antibody, where specific bands were detected at approximately 40 kDa when used with K562 human chronic myelogenous leukemia cell line and Daudi human Burkitt's lymphoma cell line .

What approach should I take to verify the specificity of SPAC5H10.01 Antibody in my experimental system?

Verifying antibody specificity is critical for ensuring reliable research results:

  • Knockout/knockdown validation:

    • Use CRISPR/Cas9 to generate SPAC5H10.01 knockout strains

    • Compare antibody signal between wild-type and knockout samples

    • Loss of signal in knockout confirms specificity

  • Mass spectrometry validation:

    • Perform immunoprecipitation with SPAC5H10.01 Antibody

    • Analyze precipitated proteins by mass spectrometry

    • Confirm that SPAC5H10.01 is the predominant protein identified

  • Epitope blocking:

    • Pre-incubate antibody with excess immunizing peptide

    • Apply to samples in parallel with unblocked antibody

    • Specific signal should be reduced or eliminated in blocked samples

  • Multiple antibody validation:

    • Use a second antibody targeting a different epitope of SPAC5H10.01

    • Compare localization or expression patterns

    • Concordant results increase confidence in specificity

This multi-faceted approach to validation is similar to methods used for other research antibodies, such as those described for the Abs-9 antibody against SpA5, where researchers used mass spectrometry to confirm specific binding after immunoprecipitation .

How can I quantify relative protein levels using SPAC5H10.01 Antibody?

Accurate quantification of protein levels requires careful attention to methodology:

  • Western blot densitometry:

    • Ensure linear range of detection (avoid saturated signals)

    • Normalize to loading controls (e.g., actin, GAPDH, or total protein stain)

    • Use at least three biological replicates

    • Apply appropriate statistical analysis

  • Flow cytometry quantification:

    • Use appropriate isotype controls to set negative populations

    • Report mean fluorescence intensity (MFI) or percent positive cells

    • Consider using quantitative beads for absolute quantification

  • Image-based quantification:

    • Maintain consistent acquisition settings across all samples

    • Use automated analysis software to reduce bias

    • Measure integrated intensity within defined regions of interest

    • Normalize to cell area or number

For example, similar approaches in flow cytometry are used for other antibodies, such as in the detection of PU.1/Spi-1 in THP-1 human acute monocytic leukemia cell line, where cells were stained with the target antibody and compared to an isotype control, with results presented as histogram distributions .

How can SPAC5H10.01 Antibody be used for co-localization studies with other yeast proteins?

Co-localization studies provide valuable insights into protein-protein interactions and functional relationships:

  • Dual immunofluorescence staining:

    • Use SPAC5H10.01 Antibody in combination with antibodies against other yeast proteins

    • Choose primary antibodies from different host species to avoid cross-reactivity

    • Use species-specific secondary antibodies with distinct fluorophores

    • Apply appropriate controls to validate staining specificity

  • Proximity ligation assay (PLA):

    • Use SPAC5H10.01 Antibody and antibody against potential interaction partner

    • Apply species-specific PLA probes

    • Perform ligation and rolling circle amplification

    • Visualize interaction points as distinct fluorescent spots

  • Quantitative co-localization analysis:

    • Calculate Pearson's correlation coefficient or Mander's overlap coefficient

    • Use ImageJ with co-localization plugins for automated analysis

    • Report both visual and statistical measures of co-localization

This approach is conceptually similar to methods used in other antibody-based research, such as the identification and characterization of antibodies against S. aureus, where multiple experimental techniques were combined to fully characterize antibody-antigen interactions .

What considerations are important when using SPAC5H10.01 Antibody for studying protein dynamics during cell cycle progression?

Studying protein dynamics during the cell cycle requires special experimental considerations:

  • Synchronization methods for S. pombe:

    • Nitrogen starvation and release

    • Hydroxyurea block and release

    • Temperature-sensitive cdc mutants

    • Select method based on specific cell cycle phase of interest

  • Time-course experimental design:

    • Collect samples at defined intervals after synchronization

    • Verify synchronization by flow cytometry or microscopy

    • Process all samples identically to ensure comparability

  • Quantification approaches:

    • Western blotting with densitometry for total protein levels

    • Immunofluorescence for spatial distribution changes

    • Fractionation studies for compartmental localization shifts

  • Considerations for data interpretation:

    • Account for cell cycle-dependent changes in reference proteins

    • Use multiple synchronization methods to confirm findings

    • Consider population heterogeneity in analyses

These approaches align with best practices in cell biology research and can be adapted based on specific research questions related to SPAC5H10.01 function during the S. pombe cell cycle.

How can SPAC5H10.01 Antibody be combined with modern proteomics approaches?

Integrating antibody-based techniques with proteomics offers powerful research opportunities:

  • Immunoprecipitation coupled to mass spectrometry (IP-MS):

    • Use SPAC5H10.01 Antibody to pull down protein complexes

    • Identify interacting partners through mass spectrometry

    • Compare interaction networks under different conditions

  • Proximity-dependent biotin identification (BioID):

    • Create fusion protein of SPAC5H10.01 with BioID enzyme

    • Validate fusion protein expression/localization with SPAC5H10.01 Antibody

    • Identify proteins in close proximity through streptavidin pull-down and MS

  • Cross-linking mass spectrometry (XL-MS):

    • Chemically cross-link protein complexes in vivo

    • Immunoprecipitate SPAC5H10.01-containing complexes

    • Identify cross-linked peptides to map interaction interfaces

This integration of antibody-based techniques with advanced proteomics is similar to approaches used in other research contexts, such as the identification of human antibodies against S. aureus through high-throughput single-cell RNA and VDJ sequencing combined with downstream characterization .

What role might SPAC5H10.01 play in stress response pathways based on current research?

While specific information about SPAC5H10.01's role in stress response is not detailed in the search results, researchers can design experiments to investigate this question:

  • Stress induction experiments:

    • Expose S. pombe cells to various stressors (oxidative, heat, osmotic)

    • Use SPAC5H10.01 Antibody to track protein expression changes

    • Compare with known stress response markers

  • Genetic interaction studies:

    • Create double mutants with known stress response genes

    • Assess synthetic phenotypes under stress conditions

    • Use SPAC5H10.01 Antibody to monitor protein levels in different genetic backgrounds

  • Phosphorylation state analysis:

    • Immunoprecipitate SPAC5H10.01 under normal and stress conditions

    • Perform phospho-specific Western blotting or mass spectrometry

    • Identify potential regulatory modifications in response to stress

This approach to investigating protein function in stress response pathways represents a standard methodology in molecular and cellular biology research, allowing for systematic characterization of protein function across different conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.